Multimodal cell tracking of a spontaneous metastasis model: Comparison between MRI, electron paramagnetic resonance and bioluminescence

Contrast Media and Molecular Imaging

Volumn 9, Issue 2, 2014, Pages 143-153

  Danhier, Pierre ^a   De Preter, Géraldine ^a   Magat, Julie ^a   Godechal, Quentin ^a   Porporato, Paolo E ^a   Jordan, Bénédicte F ^a   Feron, Olivier ^a   Sonveaux, Pierre ^a   Gallez, Bernard ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Bioluminescence; Cancer; Cell tracking; Electron paramagnetic resonance; Magnetic resonance imaging; Metastasis

Indexed keywords

BIOLUMINESCENCE; CANCER; CELL TRACKING; ELECTRON PARAMAGNETIC RESONANCE; MAGNETIC RESONANCE IMAGING; METASTASIS;

ANIMALS; CELL PROLIFERATION; CELL TRACKING; CONTRAST MEDIA; ELECTRON SPIN RESONANCE SPECTROSCOPY; FERRIC COMPOUNDS; HUMANS; KIDNEY NEOPLASMS; LUMINESCENT MEASUREMENTS; MAGNETIC RESONANCE IMAGING; MICE; NEOPLASM METASTASIS; RHODAMINES;

EID: 84893869698     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.1553     Document Type: Article

References (48)

1. Ruggiero A, Thorek D, Guenoun J, Krestin G, Bernsen M. Cell tracking in cardiac repair: what to image and how to image. Eur Radiol 2012; 22(1): 189-204.
2. Jendelová P, Herynek V, DeCroos J, Glogarová K, Andersson B, Hájek M, Syková E. Imaging the fate of implanted bone marrow stromal cells labeled with superparamagnetic nanoparticles. Magn Reson Med 2003; 50(4): 767-776.
3. Farrell E, Wielopolski P, Pavljasevic P, Kops N, Weinans H, Bernsen M, van Osch G. Cell labelling with superparamagnetic iron oxide has no effect on chondrocyte behaviour. Osteoarthritis Cartilage 2009; 17(7): 961-967.
4. Bulte J. In vivo MRI cell tracking: clinical studies. AJR Am J Roentgenol 2009; 193(2): 314-325.
5. Chen I, Greve J, Gheysens O, Willmann J, Rodriguez-Porcel M, Chu P, Sheikh A, Faranesh A, Paulmurugan R, Yang P, Wu J, Gambhir S. Comparison of optical bioluminescence reporter gene and superparamagnetic iron oxide MR contrast agent as cell markers for noninvasive imaging of cardiac cell transplantation. Molecular imaging and biology. Mol Imag Biol 2009; 11(3): 178-187.
6. Ponomarev V. Nuclear imaging of cancer cell therapies. J Nucl Med 2009; 50(7): 1013-1016.
7. Bhirde A, Xie J, Swierczewska M, Chen X. Nanoparticles for cell labeling. Nanoscale 2011; 3(1): 142-153.
8. Boehm-Sturm P, Mengler L, Wecker S, Hoehn M, Kallur T. In vivo tracking of human neural stem cells with 19F magnetic resonance imaging. PLoS One 2011; 6(12): e29040.
9. Shen J, Cheng L-N, Zhong X-M, Duan X-H, Guo R-M, Hong G-B. Efficient in vitro labeling rabbit neural stem cell with paramagnetic Gd-DTPA and fluorescent substance. Eur J Radiol 2010; 75(3): 397-405.
10. Bulte J, Kraitchman D. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 2004; 17(7): 484-499.
11. Cromer Berman S, Walczak P, Bulte J. Tracking stem cells using magnetic nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2011; 3(4): 343-355.
12. Mahmoudi M, Hosseinkhani H, Hosseinkhani M, Boutry S, Simchi A, Journeay W, Subramani K, Laurent S. Magnetic resonance imaging tracking of stem cells in vivo using iron oxide nanoparticles as a tool for the advancement of clinical regenerative medicine. Chem Rev 2011; 111(2): 253-280.
13. Cai Q-Y, Lee H, Kim E-J, Moon H, Chang K, Rho J, Hong K. Magnetic resonance imaging of superparamagnetic iron oxide-labeled macrophage infiltrates in acute-phase renal ischemia-reperfusion mouse model. Nanomedicine NBM 2012; 8(3): 365-373.
14. Foster P, Dunn E, Karl K, Snir J, Nycz C, Harvey A, Pettis R. Cellular magnetic resonance imaging: in vivo imaging of melanoma cells in lymph nodes of mice. Neoplasia 2008; 10(3): 207-216.
15. Heyn C, Ronald J, Ramadan S, Snir J, Barry A, MacKenzie L, Mikulis D, Palmieri D, Bronder J, Steeg P, Yoneda T, MacDonald I, Chambers A, Rutt B, Foster P. In vivo MRI of cancer cell fate at the single-cell level in a mouse model of breast cancer metastasis to the brain. Magn Reson Med 2006; 56(5): 1001-1010.
16. Walczak P, Kedziorek D, Gilad A, Barnett B, Bulte J. Applicability and limitations of MR tracking of neural stem cells with asymmetric cell division and rapid turnover: the case of the shiverer dysmyelinated mouse brain. Magn Reson Med 2007; 58(2): 261-269.
17. Huang N, Okogbaa J, Babakhanyan A, Cooke J. Bioluminescence imaging of stem cell-based therapeutics for vascular regeneration. Theranostics 2012; 2(4): 346-354.
18. Contag C, Ross B. It's not just about anatomy: in vivo bioluminescence imaging as an eyepiece into biology. J Magn Reson Imag 2002; 16(4): 378-387.
19. Gupta G, Massagué J. Cancer metastasis: building a framework. Cell 2006; 127(4): 679-695.
20. Fidler I. Models for spontaneous metastasis. Cancer Res 2006; 66(19): 9787.
21. Mohanty S, Xu L. Experimental metastasis assay. J Vis Exp 2010; (42): e1942.
22. Condeelis J, Weissleder R. In vivo imaging in cancer. Cold Spring Harb Perspect Biol 2010; 2: a003848.
23. Driehuys B, Nouls J, Badea A, Bucholz E, Ghaghada K, Petiet A, Hedlund L. Small animal imaging with magnetic resonance microscopy. ILAR J 2008; 49(1): 35-53.
24. Smith B, Johnson G, Groman E, Linney E. Magnetic resonance microscopy of mouse embryos. Proc Natl Acad Sci USA 1994; 91(9): 3530-3533.
25. Radermacher KA, Magat J, Bouzin C, Laurent S, Dresselaers T, Himmelreich U, Boutry S, Mahieu I, Vander Elst L, Feron O, Muller RN, Jordan BF, Gallez B. Multimodal assessment of early tumor response to chemotherapy: comparison between diffusion-weighted MRI, 1H-MR spectroscopy of choline and USPIO particles targeted at cell death. NMR Biomed 2012; 25(4): 514-522.
26. Radermacher KA, Boutry S, Laurent S, Elst LV, Mahieu I, Bouzin C, Magat J, Gregoire V, Feron O, Muller RN, Jordan BF, Gallez B. Iron oxide particles covered with hexapeptides targeted at phosphatidylserine as MR biomarkers of tumor cell death. Contrast Media Mol Imag 2010; 5(5): 258-267.
27. Radermacher KA, Beghein N, Boutry S, Laurent S, Vander Elst L, Muller RN, Jordan BF, Gallez B. In vivo detection of inflammation using pegylated iron oxide particles targeted at E-selectin: a multimodal approach using MR imaging and EPR spectroscopy. Invest Radiol 2009; 44(7): 398-404.
28. Chertok B, Cole AJ, David AE, Yang VC. Comparison of electron spin resonance spectroscopy and inductively-coupled plasma optical emission spectroscopy for biodistribution analysis of iron-oxide nanoparticles. Mol Pharm 2010; 7(2): 375-385.
29. Hillman G. Experimental animal models for investigating renal cell carcinoma pathogenesis and preclinical therapeutic approaches. In: Teicher BA editor. Tumor Models Cancer Res, Cancer Drug Discovery and Development. Humana Press, 2011; 287-305.
30. Siders W, Wright P, Hixon J, Alvord W, Back T, Wiltrout R, Fenton R. T cell- and NK cell-independent inhibition of hepatic metastases by systemic administration of an IL-12-expressing recombinant adenovirus. J Immunol 1998; 160(11): 5465-5474.
31. Campeau E, Ruhl VE, Rodier F, Smith CL, Rahmberg BL, Fuss JO, Campisi J, Yaswen P, Cooper PK, Kaufman PD. A versatile viral system for expression and depletion of proteins in mammalian cells. PLoS One 2009; 4(8): e6529.
32. Danhier P, De Preter G, Boutry S, Mahieu I, Leveque P, Magat J, Haufroid V, Sonveaux P, Bouzin C, Feron O, Muller R, Jordan B, Gallez B. Electron paramagnetic resonance as a sensitive tool to assess the iron oxide content in cells for MRI cell labeling studies. Contrast Media Mol Imag 2012; 7(3): 302-307.
33. Bulte JW, Walczak P, Gleich B, Weizenecker J, Markov DE, Aerts HC, Boeve H, Borgert J, Kuhn M. MPI Cell tracking: what can we learn from MRI? Proc Soc Photo Opt Instrum Eng 2011; 7965: 79650z.
34. Branca RT, Cleveland ZI, Fubara B, Kumar CS, Maronpot RR, Leuschner C, Warren WS, Driehuys B. Molecular MRI for sensitive and specific detection of lung metastases. Proc Natl Acad Sci USA 2010; 107(8): 3693-3697.
35. Song H-T, Jordan E, Lewis B, Liu W, Ganjei J, Klaunberg B, Despres D, Palmieri D, Frank J. Rat model of metastatic breast cancer monitored by MRI at 3 tesla and bioluminescence imaging with histological correlation. J Translat Mede 2009; 7: 88.
36. McFadden C, Mallett CL, Foster PJ. Labeling of multiple cell lines using a new iron oxide agent for cell tracking by MRI. Contrast Media Mol Imag 2011; 6(6): 514-522.
37. Ben-Hur T, van Heeswijk R, Einstein O, Aharonowiz M, Xue R, Frost E, Mori S, Reubinoff B, Bulte J. Serial in vivo MR tracking of magnetically labeled neural spheres transplanted in chronic EAE mice. Magn Reson Med 2007; 57(1): 164-171.
38. Weissleder R, Stark D, Engelstad B, Bacon B, Compton C, White D, Jacobs P, Lewis J. Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR Am J Roentgenol 1989; 152(1): 167-173.
39. Higuchi T, Anton M, Dumler K, Seidl S, Pelisek J, Saraste A, Welling A, Hofmann F, Oostendorp RA, Gansbacher B, Nekolla SG, Bengel FM, Botnar RM, Schwaiger M. Combined reporter gene PET and iron oxide MRI for monitoring survival and localization of transplanted cells in the rat heart. J Nucl Med 2009; 50(7): 1088-1094.
40. Shapiro EM, Sharer K, Skrtic S, Koretsky AP. In vivo detection of single cells by MRI. Magn Reson Med 2006; 55(2): 242-249.
41. Hinds KA, Hill JM, Shapiro EM, Laukkanen MO, Silva AC, Combs CA, Varney TR, Balaban RS, Koretsky AP, Dunbar CE. Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells. Blood 2003; 102(3): 867-872.
42. Xing W, He X, Kassir MA, Chen J, Ding J, Sun J, Hu J, Zhang Z, Haacke EM, Dai Y. Evaluating hemorrhage in renal cell carcinoma using susceptibility weighted imaging. PLoS One 2013; 8(2): e57691.
43. van den Bos EJ, Baks T, Moelker AD, Kerver W, van Geuns RJ, van der Giessen WJ, Duncker DJ, Wielopolski PA. Magnetic resonance imaging of haemorrhage within reperfused myocardial infarcts: possible interference with iron oxide-labelled cell tracking? Eur Heart J 2006; 27(13): 1620-1626.
44. Cronin M, Akin AR, Collins SA, Meganck J, Kim JB, Baban CK, Joyce SA, van Dam GM, Zhang N, van Sinderen D, O'Sullivan GC, Kasahara N, Gahan CG, Francis KP, Tangney M. High resolution in vivo bioluminescent imaging for the study of bacterial tumour targeting. PLoS One 2012; 7(1): e30940.
45. Ottobrini L, Martelli C, Trabattoni DL, Clerici M, Lucignani G. In vivo imaging of immune cell trafficking in cancer. Eur J Nucl Med Mol Imag 2011; 38(5): 949-968.
46. Cukur T, Yamada M, Overall WR, Yang P, Nishimura DG. Positive contrast with alternating repetition time SSFP (PARTS): a fast imaging technique for SPIO-labeled cells. Magn Reson Med 2010; 63(2): 427-437.
47. Zhao Q, Langley J, Lee S, Liu W. Positive contrast technique for the detection and quantification of superparamagnetic iron oxide nanoparticles in MRI. NMR Biomed 2011; 24(5): 464-472.
48. Vande Velde G, Raman Rangarajan J, Vreys R, Guglielmetti C, Dresselaers T, Verhoye M, Van der Linden A, Debyser Z, Baekelandt V, Maes F, Himmelreich U. Quantitative evaluation of MRI-based tracking of ferritin-labeled endogenous neural stem cell progeny in rodent brain. Neuroimage 2012; 62(1): 367-380.